LiveActive security incident?Get immediate response
CVE Record

CVE-2011-5125: Cross-site scripting (XSS) vulnerability in Blue Coat Director before 5.5.2.3 allows remote attackers to in...

Cross-site scripting (XSS) vulnerability in Blue Coat Director before 5.5.2.3 allows remote attackers to inject arbitrary web script or HTML via vectors involving the HTTP TRACE method.

UnknownCVSS not scoredNot KEV-listedUpdated
Glexia's TakeAutomated analysisunknown

Security readout for executives and security teams

Plain-English summary

CVE-2011-5125 is a cross-site scripting issue in Blue Coat Director versions before 5.5.2.3. A remote attacker could inject web script or HTML through vectors involving the HTTP TRACE method. Business risk depends on whether legacy Blue Coat Director is still deployed and reachable.

Executive priority

Prioritize as a legacy product exposure check, not an emergency, unless Blue Coat Director remains internet-accessible or administratively exposed.

Technical view

The CVE describes XSS in Blue Coat Director before 5.5.2.3, tied to HTTP TRACE method handling. The provided data does not include CVSS, CWE mapping, detailed affected CPEs, or vendor remediation text beyond the fixed-version implication.

Likely exposure

Exposure is likely limited to organizations still running Blue Coat Director before 5.5.2.3. Risk is higher if the Director web interface is reachable by untrusted networks or users.

Exploitation context

The provided sources do not show CISA KEV listing or active exploitation evidence. Treat exploitation status as unconfirmed based on this bundle.

Researcher notes

Evidence is sparse: no CVSS, CWE, CPE, exploit detail, or full vendor text is included. The main actionable indicator is Blue Coat Director before 5.5.2.3 and HTTP TRACE-related XSS.

Mitigation direction

  • Identify any Blue Coat Director deployments and versions.
  • Upgrade Blue Coat Director to 5.5.2.3 or later if applicable.
  • Review Blue Coat advisory SA62 for vendor-specific guidance.
  • Limit access to Blue Coat Director management interfaces to trusted administrators.

Validation and detection

  • Confirm whether Blue Coat Director exists in asset inventory.
  • Verify installed Blue Coat Director version is 5.5.2.3 or later.
  • Check exposure of Director web interfaces from untrusted networks.
  • Review logs for suspicious HTTP TRACE activity where available.
Prepared
Confidence
medium
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2011-5125 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/an/an/aListed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.